Literature DB >> 20530754

Maximizing parameters for tissue ablation by using an internally cooled electrode.

John P McGahan1, Shaun Loh, Fernando J Boschini, Eric E Paoli, John M Brock, Wayne L Monsky, Chin-Shang Li.   

Abstract

PURPOSE: To compare an algorithm of gradually ramped-up power to a full-power-level technique to determine which technical parameters maximized tissue coagulation by using a saline-perfused electrode.
MATERIALS AND METHODS: Institutional review board approval was not necessary and animal committee approval was unnecessary because an ex vivo bovine liver model was used and the animals were not specifically killed for this study. This four-part experiment utilized multiple ablations of ex vivo bovine liver with a standard radiofrequency (RF) generator and an internally cooled needle. First, 10 RF ablations were performed at 20-60 W for 12 minutes. Second, ablation volumes obtained from an algorithm of eight ablations performed at 50 W were compared with those obtained from an algorithm of eight ablations that were gradually ramped-up to 50 W, until full impedance. Third, volumes obtained from 10 ablations performed at impedance control power levels were compared with those obtained from 10 ablations performed with a gradual ramp-up of power that started at 50 W, terminating at full impedance. Last, the third part was repeated, but with 11 ablations continuing past full impedance for 12 minutes each.
RESULTS: In the first part, maximum measurements of tissue coagulation seemed to plateau from 40 to 60 W. The second part produced significantly larger measurements of tissue coagulation than did the use of a constant power level of 50 W. The third and final parts produced larger measurements of tissue coagulation than did utilizing full power for 12 minutes. Larger measurements and volumes were obtained from repeat ablations after the generator reached impedance level than were obtained from ablations stopped at maximum impedance.
CONCLUSION: A gradual ramp-up of power and repeating ablations after power impedance level is reached are the two methods that increased tissue ablation in this ex vivo experiment.

Entities:  

Mesh:

Year:  2010        PMID: 20530754      PMCID: PMC2909435          DOI: 10.1148/radiol.09090662

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor.

Authors:  W H Hall; J P McGahan; D P Link; R W deVere White
Journal:  AJR Am J Roentgenol       Date:  2000-06       Impact factor: 3.959

2.  Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode.

Authors:  S N Goldberg; G S Gazelle; L Solbiati; W J Rittman; P R Mueller
Journal:  Acad Radiol       Date:  1996-08       Impact factor: 3.173

3.  Hepatic ablation using radiofrequency electrocautery.

Authors:  J P McGahan; P D Browning; J M Brock; H Tesluk
Journal:  Invest Radiol       Date:  1990-03       Impact factor: 6.016

4.  Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

Authors:  S N Goldberg; P F Hahn; K K Tanabe; P R Mueller; W Schima; C A Athanasoulis; C C Compton; L Solbiati; G S Gazelle
Journal:  J Vasc Interv Radiol       Date:  1998 Jan-Feb       Impact factor: 3.464

5.  Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations.

Authors:  G D Dodd; M S Frank; M Aribandi; S Chopra; K N Chintapalli
Journal:  AJR Am J Roentgenol       Date:  2001-10       Impact factor: 3.959

6.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.

Authors:  L Solbiati; T Ierace; S N Goldberg; S Sironi; T Livraghi; R Fiocca; G Servadio; G Rizzatto; P R Mueller; A Del Maschio; G S Gazelle
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

7.  Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode.

Authors:  S Rossi; E Buscarini; F Garbagnati; M Di Stasi; P Quaretti; M Rago; A Zangrandi; S Andreola; D Silverman; L Buscarini
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

8.  Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure.

Authors:  D I Rosenthal; A Alexander; A E Rosenberg; D Springfield
Journal:  Radiology       Date:  1992-04       Impact factor: 11.105

9.  Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Hock-Jean Chung; Chao-Wei Hsu; Cheng-Yuan Peng
Journal:  AJR Am J Roentgenol       Date:  2003-01       Impact factor: 3.959

10.  Expansion of radiofrequency ablation volume by saturated NaCl saline injection in the area of vaporization.

Authors:  A Shimizu; H Ishizaka; S Awata; A Shiraishi; S Hirasawa; T Tatezawa; M Kano; K Shimodaira; A Taketomi-Takahashi; Y Tsushima; K Endo
Journal:  Acta Radiol       Date:  2009-01       Impact factor: 1.990

View more
  3 in total

1.  Radiofrequency and microwave ablation in a porcine liver model: non-contrast CT and ultrasound radiologic-pathologic correlation.

Authors:  Timothy J Ziemlewicz; J Louis Hinshaw; Meghan G Lubner; Emily A Knott; Bridgett J Willey; Fred T Lee; Christopher L Brace
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

2.  Thermal influence of radiofrequency ablation for bone: an experimental study in normal rabbit bone.

Authors:  Shuichi Yamamoto; Toshio Kaminou; Yuichi Ono; Masayuki Hashimoto; Yasufumi Ohuchi; Haruhiko Yoshida; Toshihide Ogawa
Journal:  Skeletal Radiol       Date:  2014-01-17       Impact factor: 2.199

Review 3.  Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.

Authors:  Yanzhao Zhou; Yi Yang; Bingyan Zhou; Zhengzheng Wang; Ruili Zhu; Xun Chen; Jingzhong Ouyang; Qingjun Li; Jinxue Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.